Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007:315:85-111.
doi: 10.1007/978-3-540-70962-6_5.

Overviews of pathogen emergence: which pathogens emerge, when and why?

Affiliations
Review

Overviews of pathogen emergence: which pathogens emerge, when and why?

S Cleaveland et al. Curr Top Microbiol Immunol. 2007.

Abstract

An emerging pathogen has been defined as the causative agent of an infectious disease whose incidence is increasing following its appearance in a new host population or whose incidence is increasing in an existing population as a result of long-term changes in its underlying epidemiology (Woolhouse and Dye 2001). Although we appear to be in a period where novel diseases are appearing and old diseases are spreading at an unprecedented rate, disease emergence per se is not a new phenomenon. It is almost certain that disease emergence is a routine event in the evolutionary ecology of pathogens, and part of a ubiquitous response of pathogen populations to shifting arrays of host species. While our knowledge of emerging diseases is, for the most part, limited to the time span of the human lineage, this history provides us with a modern reflection of these deeper evolutionary processes, and it is clear from this record that at many times throughout human history, demographic and behavioural changes in society have provided opportunities for pathogens to emerge.

PubMed Disclaimer

References

    1. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–689. doi: 10.2337/diacare.24.4.683. - DOI - PubMed
    1. Wilson PW. Estimating CVD risk and the metabolic syndrome: Framingham view. Endocrinol Metab Clin North Am. 2004;33:467–481. doi: 10.1016/j.ecl.2004.03.012. - DOI - PubMed
    1. Eckel RH, Grundy SM, Zimmet P. The metabolic syndrome. Lancet. 2005;365:9468–9415. doi: 10.1016/S0140-6736(05)66378-7. - DOI - PubMed
    1. Grundy SM. Metabolic syndrome: connecting and reconciling CV and diabetes world. J Am Coll Cardiol. 2006;47:1093–1100. doi: 10.1016/j.jacc.2005.11.046. - DOI - PubMed
    1. Lemieux I, Pascot A, Couillard C, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad. Circulation. 2000;102:179–184. - PubMed

Publication types